---
title: "Companhia Siderurgica Nacional S.A. Stock 12‑Month Price Target Raised to $1.69, Implies 32% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286397995.md"
description: "Companhia Siderurgica Nacional S.A.'s stock price target has been raised to $1.69, indicating a potential upside of 32%. This estimate comes from 11 analysts, with price forecasts ranging from $1.16 to $2.24 per share. Despite the increased target, the consensus rating remains a 'Sell' with no Buy ratings, 7 Holds, and 3 Sells. The information is sourced from FactSet and does not constitute investment advice."
datetime: "2026-05-14T10:20:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286397995.md)
  - [en](https://longbridge.com/en/news/286397995.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286397995.md)
---

# Companhia Siderurgica Nacional S.A. Stock 12‑Month Price Target Raised to $1.69, Implies 32% Upside

-   According to estimates from 11 analysts, Companhia Siderurgica Nacional S.A. stock's average price target has risen from $1.67 to $1.69, with forecasts ranging from $1.16 to $2.24 per share
-   Based on the May 13 closing price, the updated target implies approximately 32% potential upside
-   Consensus rating remains at “Sell” across 10 covering analysts, with 0 Buys, 7 Holds and 3 Sells

Explore more price target data and ratings for Companhia Siderurgica Nacional S.A. on the , and track all previous and future analyst recommendations for Companhia Siderurgica Nacional S.A. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [SID.US](https://longbridge.com/en/quote/SID.US.md)

## Related News & Research

- [Should Vishay’s Return To Profitability, Dividend, And ESOP Offering Require Action From Vishay Intertechnology (VSH) Investors?](https://longbridge.com/en/news/287251215.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)
- [Earnings Beat: Deepak Nitrite Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286980047.md)
- [Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4](https://longbridge.com/en/news/286958909.md)